Upexi, INC Form 4 insider transactions

Gene Salkind, a Director of Upexi, Inc., received 100,000 shares of common stock on 2026-07-03-05:00.

Lawrence Dugan, a Director of Upexi, Inc., received 100,000 shares of common stock on 2026-07-03-05:00.

Brian Benjamin Rudick, Chief Strategy Officer of Upexi, Inc., received 400,000 shares of common stock on 2026-07-03-05:00.

Allan Marshall, Chief Executive Officer and a Director of Upexi, Inc., received 2,000,000 shares of common stock on 2026-07-03-05:00.

Andrew James Norstrud, Chief Financial Officer and a Director of Upexi, Inc., received 400,000 shares of common stock on 2026-07-03-05:00.

UPEXI, Inc. CEO Allan Marshall acquired 50,000 shares of common stock for $1.80 per share, increasing his direct beneficial ownership to over 4 million shares.

UPEXI CEO Allan Marshall increased his beneficial ownership through a 1.6 million share grant and subsequent open market purchases totaling 150,000 shares.

UPEXI, INC. Director Gene Salkind acquired 50,000 shares of common stock for $2.55 per share, increasing his indirect beneficial ownership to 218,750 shares.

UPEXI's Chief Financial Officer, Andrew Norstrud, was granted 240,000 shares of common stock as part of the company's Equity Incentive Plan.

UPEXI Director Gene Salkind acquired 200,000 shares of common stock through direct and indirect purchases on November 17, 2025, signaling increased confidence.

Gene Salkind, a Director and 10% owner of UPEXI, Inc., significantly increased his beneficial ownership through a private placement purchase and equity incentive plan grants.

UPEXI, Inc.'s Chief Strategy Officer, Brian Rudick, was granted 400,000 shares of common stock under the company's Equity Incentive Plan, with vesting commencing July 1, 2025.

Director Lawrence Dugan of UPEXI, INC. has substantially increased his beneficial ownership in the company through a series of open market purchases and equity incentive plan grants in July 2025.

UPEXI, Inc. Director Thomas Charles Williams was granted a total of 100,000 shares of common stock through the company's Equity Incentive Plan, with varying vesting schedules.

UPEXI, Inc.'s Chief Executive Officer and Director, Allan Marshall, significantly increased his beneficial ownership through a private placement purchase and an equity incentive plan grant.

UPEXI, Inc.'s Chief Financial Officer and Director, Andrew Norstrud, was granted 250,000 shares of common stock under the company's Equity Incentive Plan.

Andrew James Norstrud, CFO of UPXI, INC., reports purchasing shares in a PIPE offering and receiving a restricted stock award.

Director Thomas Charles Williams reports acquisition of 25,000 options to buy common stock in UPEXI, INC.

CEO Allan Marshall increased his holdings in UPEXI, Inc. through a purchase of common stock and an award of warrants.

Director Gene Salkind reports purchasing 241,229 shares of UPEXI Inc. common stock at $2.28 per share and acquiring options to buy common stock.

Lawrence Dugan, a director of UPEXI, Inc. (UPXI), acquired 25,000 options to buy common stock on January 17, 2025.

CEO Allan Marshall recently purchased additional shares of UPXI, INC., increasing his direct ownership.

UPEXI, INC. CEO Allan Marshall reports the acquisition of 103,013 shares of common stock at $0.70 per share on March 5, 2024, increasing his direct holdings to 2,861,881 shares.